B. Rush Waller
YOU?
Author Swipe
View article: A 63-Year-Old Male with D-Transposition of the Great Arteries Who Had an Early Form of the Arterial Switch Operation
A 63-Year-Old Male with D-Transposition of the Great Arteries Who Had an Early Form of the Arterial Switch Operation Open
We describe a 63-year-old male who appears to have undergone an early form of the arterial switch operation for D-transposition of the great arteries performed in the mid-1960s. We review the clinical and imaging data that support our conc…
View article: O-4 | Low Risk of Thyroid Dysfunction in Children <3 Years After Exposure to Iodine-Containing Contrast Agents in Cardiac Catheterization
O-4 | Low Risk of Thyroid Dysfunction in Children <3 Years After Exposure to Iodine-Containing Contrast Agents in Cardiac Catheterization Open
Angiography during cardiac catheterization procedures in children is performed using iodinated contrast media (ICM). On March 31, 2022, the U.S. Food and Drug Administration (FDA) released a drug safety communication recommending evaluatio…
View article: D-13 | Initial Utility Testing of Virtual Reality Modeling for Pre-Procedural Planning in Congenital Cardiac Interventions
D-13 | Initial Utility Testing of Virtual Reality Modeling for Pre-Procedural Planning in Congenital Cardiac Interventions Open
The complexity of procedures performed by congenital interventional cardiologists has increased. As adult structural interventionalists have moved further towards pre-procedural imaging and planning, pediatric interventionalists do not rou…
View article: B-44 | Initial Experience of the Cardiva VASCADE® Vascular Closure System in Pediatric Cardiac Catheterizations
B-44 | Initial Experience of the Cardiva VASCADE® Vascular Closure System in Pediatric Cardiac Catheterizations Open
BackgroundThe Cardiva Medical VASCADE® and VASCADE® MVP are extravascular, integrated, and bioabsorbable vascular access closure systems that are FDA approved for use in femoral vessels. However, their use in pediatrics has not yet been we…
View article: O-3 | Transitioning from the Cardiac Catheterization Lab to the Bedside for Transcatheter PDA Device Closure in ELBW Infants: A Single Center Experience
O-3 | Transitioning from the Cardiac Catheterization Lab to the Bedside for Transcatheter PDA Device Closure in ELBW Infants: A Single Center Experience Open
BackgroundTranscatheter Patent ductus arteriosus (PDA) closure (TCPC) is feasible and safe in infants weighing ≤ 1 kg. These extremely low birth weight (ELBW) infants are most vulnerable to transport between hospitals and out of their safe…
View article: B-38 | Decannulation of Percutaneously Placed Veno-Arterial ECMO Cannulas in Children by the Pediatric Interventional Cardiologist
B-38 | Decannulation of Percutaneously Placed Veno-Arterial ECMO Cannulas in Children by the Pediatric Interventional Cardiologist Open
BackgroundDecannulation from veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in the pediatric population has historically been performed by surgeons. We have previously described techniques for successful percutaneous VA-ECMO c…
View article: Feasibility and Safety of Percutaneous Cardiac Interventions for Congenital and Acquired Heart Defects in Infants ≤1000 g
Feasibility and Safety of Percutaneous Cardiac Interventions for Congenital and Acquired Heart Defects in Infants ≤1000 g Open
The transcatheter closure of patent ductus arteriosus (TCPC) has been demonstrated to be feasible even in infants weighing ≤1000 g. However, other percutaneous cardiac interventions (PCI) for such small infants born with congenital heart d…
View article: Reduced intensity chemotherapy, tyrosine kinase inhibitor, and blinatumomab in a pediatric patient with Philadelphia chromosome-positive ALL and mechanical valves
Reduced intensity chemotherapy, tyrosine kinase inhibitor, and blinatumomab in a pediatric patient with Philadelphia chromosome-positive ALL and mechanical valves Open
The outcome of pediatric patients with Philadelphia chromosome (Ph)-positive acute lymphoid leukemia (ALL) has improved with addition of tyrosine kinase inhibitors to an intense chemotherapy. However, it is associated with high incidences …
View article: The Medtronic Micro Vascular Plug™ for Vascular Embolization in Children With Congenital Heart Diseases
The Medtronic Micro Vascular Plug™ for Vascular Embolization in Children With Congenital Heart Diseases Open
Objectives To describe the early multi‐center, clinical experience with the Medtronic Micro Vascular Plug™ (MVP) in children with congenital heart disease (CHD) undergoing vascular embolization. Background The MVP is a large diameter vascu…